CTRI/2020/09/027904尚未招募未知
Autologous whole blood injection as treatment for Covid-19 infection
Dr M Christopher0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Patients in the age group of 14 years and above
- •2) Both male and female patients
- •3) Confirmed cases of COVID 19 admitted for treatment in Shifa hospital; COVID positive confirmed by RT-PCR
- •4) Presence of IgM antibodies through rapid test kit
- •5) Willing to give consent for the study and take part actively
- •6) Patients willing to adhere to drugs protocol as per ICMR guidelines/ WHO guidelines
- •7) In test arm, patients who are accepting to AWB therapy in addition to standard drugs
排除标准
- •1) Children lesser than 14 years of age
- •2) Presence of IgG antibodies through rapid test kit
- •3) Patients hypersensitive to blood products or blood transfusion
- •4) Any Co-morbid conditions
- •5) Patients who are critically ill are excluded from the study
研究者
相似试验
招募中
不适用
Clinical Study of autologous blood injection for the treatment of recurrent temporomandibular joint dislocatioJPRN-UMIN000022197Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Oral and Maxillofacial Surgery20
尚未招募
不适用
Autologous Peripheral Blood Stem Cell Treatment for Myocardial Regeneration in Acute Myocardial InfarctioDiseases of the circulatory systemKCT0006114Seoul National University Hospital105
已完成
不适用
Autologous conditioned plasma injection for acute hamstring muscle injury.hamstring rupturehamstring strain10028302NL-OMON37939Arthrex Medizinische Instrumente GmbH80
终止
不适用
Application of autologous peripheral blood-derived stem cell/progenitor cell (CD34+) + stem cells and hyperbaric oxygen therapy for patients with severe limb ischemiaISRCTN80181257Ministry of Science and Technology (Taiwan)40
未知
不适用
Peripheral blood mononuclear cell implantation for patients with severe ischemic heart diseaseSevere ischemic heart diseaseJPRN-UMIN000001289Department of Cardiovascular Science and Medicine,Graduate School of Medicine,Chiba University30